← Oncology Approval Tracker

FDA DECISION ·

Padcev

enfortumab vedotin-ejfv · Astellas Pharma

Traditional approvalTraditional conversionUrothelial carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Adults with locally advanced or metastatic urothelial carcinoma after both a PD-1 or PD-L1 inhibitor and platinum-containing chemotherapy.

LAMPGEN ANALYSIS

Why it matters

This converts the post-platinum and checkpoint inhibitor population from accelerated to traditional approval.

What research teams should watch

Capture prior treatment class and timing, with consistent follow-up for neuropathy and skin reactions.

PRIMARY RECORDS

Sources